Pradaxa Overview

Pradaxa is a new blood-thinning medicine primarily used to reduce the risk of stroke and blood clots in patients with atrial fibrillation not caused by a heart valve problem. However, recent studies show that patients taking Pradaxa instead of established blood-thinning medicines have a higher risk of life-threatening bleeds. Additionally, Pradaxa was placed on the market by German manufacturer Boehringer Ingelheim Pharmaceuticals with no known antidote, meaning that doctors cannot stop a bleed once it starts. Thus, even a small scrape or cut can lead to a life-threatening bleeding situation.

Lawsuits have been filed in federal court alleging that Pradaxa’s manufacturer knew of these increased risks and failed to adequately warn patients and doctors. If these allegations are proven true, patients taking Pradaxa may be entitled to compensation for injuries they sustained while on the drug. If you or a loved one has suffered a life-threatening bleed or death after taking Pradaxa, call our team of Pradaxa attorneys to discuss your case.